Zydelig: Mechanism of Action (MOA) Video
For the launch of Gilead's first oncology drug Zydelig, we created an MOA video that showed how the drug targets the Kinase Pi3k∂ in malignant B cells. The video launched on the professional website and was shown at ASCO conference. We concepted and scripted the story and established the visual style of the video.
